Eli Lilly is suing six entities that it alleges are selling black market versions of its experimental weight-loss drug retatrutide. Lilly’s lawsuits target U.S. entities selling illegal retatrutide products, including compounding pharmacies, medical spas and online sellers that sell retatrutide as a weight-loss “hack.” Those entities falsely claim their drugs are for “research-use only” when…
Politics
·
Eli Lilly targets alleged black market sales of its experimental GLP-1 drug
CN
CitrixNews Staff
Originally reported by The Hill. Read the full story at the original source.
Related Articles
Politics
Thousands of No Kings protests held for nationwide early voting ‘day of action’
Thousands of “No Kings” protests are being held across the country on Saturday for a “nationwide day of action” amid the...
CitrixNews Staff
·
1 hour ago
Politics
Immigrant ICE searched for in Texas when agent hit man with car has been dead for years: Report
The immigrant that federal agents were pursuing when an Immigration and Customs Enforcement (ICE) officer hit and injure...
CitrixNews Staff
·
1 hour ago
Politics
America’s $40 trillion debt is coming for your wallet
As the U.S. national debt surpassed $40 trillion during Donald Trump's second term, critics warned that escalating inter...
CitrixNews Staff
·
1 hour ago
Politics
Schumer: ‘Trump just gave Putin the best birthday gift he’ll get this year’
Senate Minority Leader Chuck Schumer (D-N.Y.) accused President Trump on Saturday of giving Russian President Vladimir P...
CitrixNews Staff
·
2 hours ago